Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.5 USD | +2.81% | -3.79% | -19.58% |
05-10 | UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating | MT |
05-09 | Transcript : Privia Health Group, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.58% | 2.15B | |
+17.33% | 83.07B | |
-30.05% | 70.89B | |
+3.59% | 28.32B | |
-7.88% | 17.73B | |
+2.07% | 17.43B | |
+0.18% | 15.64B | |
+6.75% | 13.46B | |
+8.40% | 12.82B | |
+69.21% | 12.69B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Privia Health Group's Q3 Adjusted Earnings, Revenue Rise; 2023 Revenue Outlook Updated